Limbix News

Limbix Names Dr. Jeffrey I. Gold as Chief Clinical Officer to Lead Clinical Trial Protocol Development & Implementation for Adolescent Mental Health Digital Therapeutics

Dr. Gold is a pediatric psychologist and full professor at USC Keck School of Medicine and has been working with teens and children for over 30 years.

May 6, 2021

Limbix Awarded $3.6M NIMH Fast-Track SBIR Grant to Develop a Prescription Digital Therapeutic for Adolescent Depression

The $3.6M NIMH Fast-Track SBIR grant will support a large-scale pivotal clinical trial conducted in partnership with the Duke Clinical Research Institute.

February 26, 2021

KidsX, the Largest Pediatric-Focused Digital Health Accelerator in the World, Selects 13 Startups for Inaugural Cohort

KidsX brings together top children’s hospitals and health startups to create digital solutions that will transform pediatric care for children and their families

January 14, 2021

Limbix digital therapeutic for adolescent mental health finds niche amid Covid-19 pandemic

The Silicon Valley startup plans to start its registration-directed study of Limbix Spark in the earlier part of next year and - if successful - would anticipate FDA clearance in early 2022.

October 12, 2020

And the winners of INVEST Digital Health Virtual Pitch Perfect contest are…..

The INVEST Digital Health Virtual conference Pitch Perfect competition, from September 21-25, had some intense competition between the healthcare startup participants. Thanks to all the entrepreneurs, judges and sponsors who took part.

September 28, 2020

DTx regulatory teams talk the power of research beyond ticking FDA's boxes

Limbix CMO Dr. Cruz discusses the difference between 510(k) clearances and enforcement discretions, and why research should go beyond the FDA threshold.

September 17, 2020

CTIP Announces COVID-19 FlexGrants Winners

The West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) announced in April the launch of its COVID-19 FlexGrants

June 26, 2020

Palo Alto company Limbix grabs $9M to develop a digital therapeutic for teens with depression

GSR Ventures led the round with participation from Sequoia Capital, Storm Ventures, NextGen Venture Partners and BIXINK Therapeutics.

May 6, 2020

Limbix Raises $9M Series A To Develop Digital Therapeutics for Adolescent Mental Health

The new funding enables further research and development of the company’s flagship product, Limbix Spark, the first prescription digital therapeutic designed to treat adolescents with depression.
May 6, 2020

May 6, 2020

Elise Ogle is turning digital devices into therapeutic ones

Welcome to #TheNextWave, a conversation series with the Headstream Accelerator Finalists who want to use social tech for the good of humanity.

February 13, 2020

MassChallenge announces its startup class of 2020

This year's cohort includes 27 companies that are working on everything from digital therapeutics to care coordination tools, to clinician workflow platforms, to opioid alternatives.

December 18, 2019

Novartis-partnered TrialSpark pens 'digital' trial collab with Limbix

Clinical study tech company TrialSpark teamed up with digital mental health firm Limbix to work on a new “digital therapeutic” for adolescent depression.

October 24, 2019